These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 34740097

  • 1. Tongxinluo prevents chronic obstructive pulmonary disease complicated with atherosclerosis by inhibiting ferroptosis and protecting against pulmonary microvascular barrier dysfunction.
    Wang Y, Kuang X, Yin Y, Han N, Chang L, Wang H, Hou Y, Li H, Li Z, Liu Y, Hao Y, Wei Y, Wang X, Jia Z.
    Biomed Pharmacother; 2022 Jan; 145():112367. PubMed ID: 34740097
    [Abstract] [Full Text] [Related]

  • 2. Tongxinluo enhances the effect of atorvastatin on the treatment of atherosclerosis with chronic obstructive pulmonary disease by maintaining the pulmonary microvascular barrier.
    Kuang X, Wang Y, Liu S, Chang L, Yin Y, Li Z, Liu Y, Li W, Hou Y, Wang H, Liang J, Jia Z.
    Food Sci Nutr; 2023 Jan; 11(1):390-407. PubMed ID: 36655081
    [Abstract] [Full Text] [Related]

  • 3. Chinese medicine Tongxinluo reduces atherosclerotic lesion by attenuating oxidative stress and inflammation in microvascular endothelial cells.
    Wu XL, Zheng B, Jin LS, Zhang RN, He M, Yang Z, Wen JK.
    Int J Clin Exp Pathol; 2015 Jan; 8(6):6323-33. PubMed ID: 26261508
    [Abstract] [Full Text] [Related]

  • 4. Tongxinluo may stabilize atherosclerotic plaque via multiple mechanisms scanning by genechip.
    Ma J, Qiao L, Meng L, Ma L, Zhao Y, Liu X, Ni M, Zhang Y.
    Biomed Pharmacother; 2019 May; 113():108767. PubMed ID: 30870720
    [Abstract] [Full Text] [Related]

  • 5. Traditional Chinese medication Tongxinluo attenuates apoptosis in ox-LDL-stimulated macrophages by enhancing Beclin-1-induced autophagy.
    Chen Y, Li M, Zhang Y, Di M, Chen W, Liu X, Yu F, Wang H, Zhen X, Zhang M.
    Biochem Biophys Res Commun; 2018 Jun 22; 501(2):336-342. PubMed ID: 29550482
    [Abstract] [Full Text] [Related]

  • 6. Tongxinluo Improves Apolipoprotein E-Deficient Mouse Heart Function.
    Yuan GQ, Gao S, Geng YJ, Tang YP, Zheng MJ, Shelat HS, Collins S, Wu HJ, Wu YL.
    Chin Med J (Engl); 2018 Mar 05; 131(5):544-552. PubMed ID: 29483388
    [Abstract] [Full Text] [Related]

  • 7. Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells.
    Qi K, Yang Y, Geng Y, Cui H, Li X, Jin C, Chen G, Tian X, Meng X.
    Medicine (Baltimore); 2020 Aug 21; 99(34):e21821. PubMed ID: 32846824
    [Abstract] [Full Text] [Related]

  • 8. Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway.
    Qi K, Li X, Geng Y, Cui H, Jin C, Wang P, Li Y, Yang Y.
    PLoS One; 2018 Aug 21; 13(6):e0198403. PubMed ID: 29912977
    [Abstract] [Full Text] [Related]

  • 9. Dihydroquercetin suppresses cigarette smoke induced ferroptosis in the pathogenesis of chronic obstructive pulmonary disease by activating Nrf2-mediated pathway.
    Liu X, Ma Y, Luo L, Zong D, Li H, Zeng Z, Cui Y, Meng W, Chen Y.
    Phytomedicine; 2022 Feb 21; 96():153894. PubMed ID: 34942457
    [Abstract] [Full Text] [Related]

  • 10. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.
    Ma L, Ni M, Hao P, Lu H, Yang X, Xu X, Zhang C, Huang S, Zhao Y, Liu X, Zhang Y.
    Oncotarget; 2016 Mar 29; 7(13):16194-204. PubMed ID: 26908443
    [Abstract] [Full Text] [Related]

  • 11. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition.
    Yin Y, Zhang Q, Zhao Q, Ding G, Wei C, Chang L, Li H, Bei H, Wang H, Liang J, Jia Z.
    Biomed Res Int; 2019 Mar 29; 2019():6595437. PubMed ID: 31317035
    [Abstract] [Full Text] [Related]

  • 12. Tongxinluo (TXL), a Traditional Chinese Medicinal Compound, Improves Endothelial Function After Chronic Hypoxia Both In Vivo and In Vitro.
    Zheng CY, Song LL, Wen JK, Li LM, Guo ZW, Zhou PP, Wang C, Li YH, Ma D, Zheng B.
    J Cardiovasc Pharmacol; 2015 Jun 29; 65(6):579-86. PubMed ID: 26065642
    [Abstract] [Full Text] [Related]

  • 13. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy.
    Zhang L, Liu Y, Lu XT, Wu YL, Zhang C, Ji XP, Wang R, Liu CX, Feng JB, Jiang H, Xu XS, Zhao YX, Zhang Y.
    Am J Physiol Heart Circ Physiol; 2009 Dec 29; 297(6):H2004-14. PubMed ID: 19801495
    [Abstract] [Full Text] [Related]

  • 14. [Effect of Tongxinluo on Apoptosis of Rat Cardiac Microvascular Endothelial Cells].
    Wei G, Li HR, Liu HL, Yao B, Chen M, Liang JQ, Jia ZH, Wu YL.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun 29; 36(6):709-17. PubMed ID: 27491231
    [Abstract] [Full Text] [Related]

  • 15. Myostatin/HIF2α-Mediated Ferroptosis is Involved in Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease.
    Zhang L, Li D, Chang C, Sun Y.
    Int J Chron Obstruct Pulmon Dis; 2022 Jun 29; 17():2383-2399. PubMed ID: 36185172
    [Abstract] [Full Text] [Related]

  • 16. Chinese medicine Tongxinluo increases tight junction protein levels by inducing KLF5 expression in microvascular endothelial cells.
    Li LM, Zheng B, Zhang RN, Jin LS, Zheng CY, Wang C, Zhou PP, Guo ZW, Ma D, Wen JK.
    Cell Biochem Funct; 2015 Jun 29; 33(4):226-34. PubMed ID: 25907265
    [Abstract] [Full Text] [Related]

  • 17. Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.
    Xu J, Ma C, Chen M, Rong S, Gao H, Xia Z, Huang F.
    Lipids Health Dis; 2018 Jul 31; 17(1):182. PubMed ID: 30064511
    [Abstract] [Full Text] [Related]

  • 18. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR-/- mice.
    Shi J, Yang MM, Yang S, Fan F, Zheng G, Miao Y, Hua Y, Zhang J, Cheng Y, Liu S, Guo Y, Guo L, Yang X, Fan G, Ma C.
    Phytomedicine; 2024 Jun 31; 128():155489. PubMed ID: 38569295
    [Abstract] [Full Text] [Related]

  • 19. Berberine as a novel ACSL4 inhibitor to suppress endothelial ferroptosis and atherosclerosis.
    Hong Y, Feng J, Dou Z, Sun X, Hu Y, Chen Z, Liu L, Xu H, Du M, Tang P, Liu X, Zhang Y.
    Biomed Pharmacother; 2024 Aug 31; 177():117081. PubMed ID: 38971008
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice.
    Sun GB, Qin M, Ye JX, Pan RL, Meng XB, Wang M, Luo Y, Li ZY, Wang HW, Sun XB.
    Toxicol Appl Pharmacol; 2013 Aug 15; 271(1):114-26. PubMed ID: 23639522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.